The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
Ranibizumab comparable to laser for PDR
A randomized trial from DRCR.net has shown ranibizumab is as effective as panretinal photocoagulation in treating PDR, and better than laser in preserving patients’ peripheral and night vision.
We extend our deepest gratitude to our Platinum, Gold, and Silver partners. Your generous support fuels our mission to advance medical education, advocate for patient safety, and foster breakthrough innovations across West Virginia.